Journal article
Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Version of record, pdf, 3.0MB)
-
- Publisher copy:
- 10.1371/journal.pmed.0050227
Why is the content I wish to access not available via ORA?
Bibliographic data (the information relating to research outputs) and full-text items (e.g. articles, theses, reports, etc.) arrive in ORA from several different sources. Unfortunately we are not able to make available the full-text for every research output.
Please contact the ORA team (
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
Content may be unavailable for the following four reasons
-
Version unsuitable
-
We have not obtained a suitable full-text for a given research output. See this page for more information.
-
Recently completed
-
Sometimes content is held in ORA but is unavailable for a fixed period of time to comply with the policies and wishes of rights holders.
-
Permissions
-
All content made available in ORA should comply with relevant rights, such as copyright. See this page for more information.
-
Clearance
-
Some thesis volumes scanned as part of the digitisation scheme funded by Dr Leonard Polonsky are currently unavailable due to sensitive material or uncleared third-party copyright content. We are attempting to contact authors whose theses are affected.
Alternative access to the full-text
You may be able to access the full-text directly from the publisher's website using the 'Publisher Copy' link in the 'Links & Downloads' box from a research output's ORA record page. This method may require an institutional or individual subscription to the journal/resource.
Authors
Funding
+ "German Research Foundation (DFG)", "Kenyan Medical Research Institute"
More from this funder
Funding agency for:
Borrmann, S
Grant:
SFB 544, A7
+ "Wellcome Trust", "Kenyan Medical Research Institute"
More from this funder
Funding agency for:
Snow, R
+ "Wellcome Trust", "Kenyan Medical Research Institute"
More from this funder
Funding agency for:
White, N
Bibliographic Details
- Publisher:
- Public Library of Science Publisher's website
- Journal:
- PLoS Medicine Journal website
- Volume:
- 5
- Issue:
- 11
- Article number:
- e227
- Publication date:
- 2008-11-01
- DOI:
- EISSN:
-
1549-1676
- ISSN:
-
1549-1277
Item Description
- Language:
- English
- Keywords:
- Subjects:
- UUID:
-
uuid:a830990b-e015-4f00-8b57-63ebd2036141
- Local pid:
- ora:2505
- Deposit date:
- 2009-01-09
Related Items
Terms of use
- Copyright holder:
- Borrmann et al
- Copyright date:
- 2008
- Notes:
- Citation: Borrmann, S. et al. (2008). 'Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria', PLoS Medicine, 5(11), e227. [Available at http://medicine.plosjournals.org]. © 2008 Borrmann et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record